Rammohan Devulapally, PhD

Sr. Director & Head of Nonviral Delivery @GranzaBio, | LNPs, Targeted Delivery & Gene Editing | Ex-@LifeEditTx, @BreezeBio_Inc, @ReCodeTx, | @StanfordMed Alumni

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 Thanks, Michael. All is well, hope the same for you and your family.

[Rammohan Devulapally, PhD @ramdevula]

As someone working in genetic medicines and in vivo delivery, I find it fascinating that longevity biotech is emerging as a major investment thesis beyond AI. @Mykalt45 https://t.co/HLDG4w7p0M

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 Good talk, Michael! I enjoyed it!

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 You did a great job closing now rather than waiting many more years for a better deal.

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 @CrossBridgeBio Congrats, Michael! Kudos to you!

[Rammohan Devulapally, PhD @ramdevula]

@CodifyBaseball Cricket Spinners in Baseball!

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 So sorry for your loss, Michael. Sending you and your family strength and love. Your dad’s pride in you truly lives on.

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 @CrossBridgeBio Thinking of you and your family during this difficult time. Having worked with you at ReCode, I know the dedication and heart you bring—no doubt your dad is incredibly proud of what you’re building at CrossBridge Bio.

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 @CrossBridgeBio Congrats, Michael! Huge kudos on securing the funding—so well deserved!”

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 I couldn’t agree more

[Rammohan Devulapally, PhD @ramdevula]

@DJSiegwart @AcadofInventors Congratulations,Dan. Well deserved

[Nicole M. Gaudelli @NicoleGaudelli]

.@SecKennedy - thank you so much for your broad support for gene editing and gene therapies as well as recognizing the importance of Baby KJ’s story and the potential that CRISPR base editing therapies hold for patients with severe genetic diseases. I’m thrilled you have publicly recognized the Herculean efforts that made KJs therapy possible, from the physicians @CHOP like @kiranmusunuru and Rebecca Ahrens-Nicklas to the technological innovation in @davidrliu and @BKleinstiver labs, and especially the coordination and cooperation of the regulators @US_FDA that made this possible.

The gene editing medicine KJ received, a CRISPR adenine base editor was invented and developed in @davidrliu lab @Harvard with government grants from the NIH. This life-saving medicine, and so many future technologies, could not and will not be possible without government grants such as the one that supported this work, but are now shut off by this administration.

So PLEASE ask this administration to stop attacking our academic institutions and restore government funding to @Harvard (where again, KJ’s medicine was created!!) We cannot have stories like KJ’s without full and unwavering support from the US government.

Please help, please.

[Stanford University @Stanford]

Remarkable new findings, published April 2 in @Nature, support an emerging theory that viruses that affect the nervous system can increase the risk of dementia. If further confirmed, they suggest a preventive intervention is already close at hand. https://t.co/N4bJTRTZNS

[Rammohan Devulapally, PhD @ramdevula]

HC Bioscience closes doors after seeing early data for tRNA asset @Mykalt45

https://t.co/MBpmcgwtO3

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 Happy New Year, Michael!

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 Happy thanksgiving, Michael!

[Rammohan Devulapally, PhD @ramdevula]

@Mykalt45 Congrats, Michael! Kudos!

[Rammohan Devulapally, PhD @ramdevula]

@ZhenpengQin @UTDallasNews Congrats, Zhenpeng!

[Rammohan Devulapally, PhD @ramdevula]

@GDE_UTSW @DJSiegwart @utswnews Congrats, Dan!